Literature DB >> 17386275

Ranibizumab according to need: a treatment for age-related macular degeneration.

Richard Spaide.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17386275     DOI： 10.1016/j.ajo.2007.02.024

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  59 in total

Review 1.  Optical Coherence Tomography Monitoring Strategies for A-VEGF-Treated Age-Related Macular Degeneration: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2014-08-01

Review 2.  The treatment of wet age-related macular degeneration.

Authors:  Antonia M Joussen; Norbert Bornfeld
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

3.  One-year outcomes of a treat-and-extend regimen of intravitreal aflibercept for polypoidal choroidal vasculopathy.

Authors:  Mio Hosokawa; Yuki Morizane; Masayuki Hirano; Shuhei Kimura; Fumiaki Kumase; Yusuke Shiode; Shinichiro Doi; Shinji Toshima; Mika Hosogi; Atsushi Fujiwara; Toshiharu Mitsuhashi; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2016-12-07       Impact factor: 2.447

4.  Difference in treatment burden of neovascular age-related macular degeneration among different types of neovascularization.

Authors:  Ji Hyun Lee; Jae Hui Kim; Jong Woo Kim; Chul Gu Kim; Dong Won Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-06       Impact factor: 3.117

5.  Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.

Authors:  Masahiro Morimoto; Hidetaka Matsumoto; Kensuke Mimura; Hideo Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-01       Impact factor: 3.117

Review 6.  A systematic review to assess the 'treat-and-extend' dosing regimen for neovascular age-related macular degeneration using ranibizumab.

Authors:  S R Rufai; H Almuhtaseb; R M Paul; B L Stuart; T Kendrick; H Lee; A J Lotery
Journal:  Eye (Lond)       Date:  2017-05-05       Impact factor: 3.775

Review 7.  Clinical pharmacology of intravitreal anti-VEGF drugs.

Authors:  Stefano Fogli; Marzia Del Re; Eleonora Rofi; Chiara Posarelli; Michele Figus; Romano Danesi
Journal:  Eye (Lond)       Date:  2018-02-05       Impact factor: 3.775

Review 8.  Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration.

Authors:  James E Frampton
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

9.  Aflibercept in wet age-related macular degeneration: a perspective review.

Authors:  Matthew Ohr; Peter K Kaiser
Journal:  Ther Adv Chronic Dis       Date:  2012-07       Impact factor: 5.091

10.  Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010.

Authors:  Salomon Y Cohen; Lise Dubois; Sandrine Ayrault; Pauline Dourmad; Corinne Delahaye-Mazza; Franck Fajnkuchen; Sylvia Nghiem-Buffet; Gabriel Quentel; Ramin Tadayoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-19       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.